PMID- 34795495 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220428 IS - 1178-7007 (Print) IS - 1178-7007 (Electronic) IS - 1178-7007 (Linking) VI - 14 DP - 2021 TI - The Prevalence and Control of Type 2 Diabetes Mellitus in Residents of a Rural Town, Shandong Province, China. PG - 4505-4512 LID - 10.2147/DMSO.S338728 [doi] AB - OBJECTIVE: To understand the prevalence and control of type 2 diabetes mellitus (T2DM) in a rural area, a cross-sectional study was carried out. METHODS: Blood glucose was determined in residents over 60 years during the National Basic Public Health Service project carrying on in a rural town of Shandong province. Combined with detail information of diabetic history, the prevalence rate of this disease was calculated with a cutoff of more than 7.0 mmol/L of fasting plasma glucose (FPG). Furthermore, according to FPG levels, the control rate of diabetes was evaluated. Basic information and clinical laboratory tests were analyzed with proper methods for univariate analysis. Multivariable logistic analysis was used to explore multiple variables associated with the control effect of T2DM. RESULTS: The prevalence rate of T2DM was 13.5% (95% CI 12.4%~14.7%) without age difference in residents over 60-year old (X (2)= 1.078, P = 0.898). And the rate was higher in the female (16.1%, 95% CI 14.4%~17.8%) than that in the male (11.3%, 95% CI 9.7%~12.9%). The control rate of diabetes was 44.5% (95% CI 39.4-49.6%, cutoff <6.1 mmol/L for FPG) and 59.6% (95% CI 54.5-64.6%, cutoff <7.0 mmol/L for FPG), respectively. Most T2DM residents had balance foods, and a high proportion of drugs or insulin were used; however, the proportion of keeping exercise and modifying behaviors was low. Nearly 80% of the diabetic individuals used at least one drug or insulin. However, the more drugs or insulin used, the higher the FPG level was. CONCLUSION: A relative high level of T2DM prevailed in the rural area under fast economy-transforming. T2DM was controlled poor and measures should be further optimized to achieve ideal effect, especially for the use of anti-diabetic drugs. CI - (c) 2021 Wei et al. FAU - Wei, Maoti AU - Wei M AUID- ORCID: 0000-0003-1203-0437 AD - Center of Clinical Epidemiology, TEDA International Cardiovascular Hospital, Tianjin, People's Republic of China. FAU - Dong, Li AU - Dong L AD - Department of Pediatrics, Center Hospital of Beikuo Town, Rizhao City, Shandong Province, People's Republic of China. FAU - Wang, Fenghua AU - Wang F AD - Center of Clinical Epidemiology, TEDA International Cardiovascular Hospital, Tianjin, People's Republic of China. FAU - Cui, Kai AU - Cui K AD - Department of Disease Prevention and Control, Hospital of Gaoxing Town, Rizhao City, Shandong Province, People's Republic of China. FAU - Ma, Delong AU - Ma D AD - Department of Pediatrics, Center Hospital of Beikuo Town, Rizhao City, Shandong Province, People's Republic of China. FAU - Yang, Ning AU - Yang N AD - Department of Hypertension, TEDA International Cardiovascular Hospital, Tianjin, People's Republic of China. FAU - Li, Yuming AU - Li Y AD - Department of Hypertension, TEDA International Cardiovascular Hospital, Tianjin, People's Republic of China. LA - eng PT - Journal Article DEP - 20211111 PL - New Zealand TA - Diabetes Metab Syndr Obes JT - Diabetes, metabolic syndrome and obesity : targets and therapy JID - 101515585 PMC - PMC8593350 OTO - NOTNLM OT - rural area OT - the control of diabetes OT - type 2 diabetes mellitus COIS- The authors report no conflicts of interest in this work. EDAT- 2021/11/20 06:00 MHDA- 2021/11/20 06:01 PMCR- 2021/11/11 CRDT- 2021/11/19 06:52 PHST- 2021/09/14 00:00 [received] PHST- 2021/10/21 00:00 [accepted] PHST- 2021/11/19 06:52 [entrez] PHST- 2021/11/20 06:00 [pubmed] PHST- 2021/11/20 06:01 [medline] PHST- 2021/11/11 00:00 [pmc-release] AID - 338728 [pii] AID - 10.2147/DMSO.S338728 [doi] PST - epublish SO - Diabetes Metab Syndr Obes. 2021 Nov 11;14:4505-4512. doi: 10.2147/DMSO.S338728. eCollection 2021.